Overview
A well-established Pharmaceutical Manufacturing Company is available for sale, offering a strong opportunity to acquire a large-scale, WHO-GMP certified manufacturing facility with an established operational track record. Established in 2006, the company operates from a substantial 55,000 sq. m. land parcel, with a covered manufacturing facility designed in accordance with WHO-GMP requirements. The facility specializes in the manufacturing of Injectables, Large Volume Parenterals (LVP), and Small Volume Parenterals (SVP). Its LVP production facility comprises 7 German machines with a capacity of approximately 5.5 lakh bottles per day, while the SVP division includes 2 ampoule lines with a monthly capacity of approximately 28 million units. Around 75% of the manufacturing capacity is booked, supported by export business and contract manufacturing arrangements, along with 15+ priority manufacturing clients. The company has fixed assets valued at approximately ₹680 Cr, annual turnover of around ₹257 Cr, and a workforce of approximately 1,050 employees. This is a strategic acquisition opportunity for pharmaceutical companies, investors, and industry players seeking an established manufacturing platform with significant scale and capacity.
Business Details
Describe Property
N.A
Competition / Market
high
Products & Services
Injectibles, LVP, SVP, WHO-GMP Certified Unit.
Growth Potential
very high
Reason For Sale
Due to Personal Reason
Financial Details
How the Acquisition Process Works
- 01Share Your RequirementsDefine your acquisition goals and preferences.
- 02Explore OpportunitiesReview curated businesses matching your criteria.
- 03Evaluate & ValueAnalyse financials, potential, and valuation.
- 04Due DiligenceVerify business, legal, and financial aspects.
- 05Complete AcquisitionNegotiate, close, and take ownership.